Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency ( GPI ) using repeated intrauterine transfusions: a case report

  • Adama van Scheltema P
  • Zhang A
  • Ball L
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hemolytic anemia due to GPI deficiency can be severe and life threatening during fetal life. When parents decline invasive testing, ultrasound monitoring of fetuses at risk is feasible. Intrauterine transfusion can be effective for the treatment of severe fetal anemia due to GPI deficiency.

Cite

CITATION STYLE

APA

Adama van Scheltema, P. N., Zhang, A., Ball, L. M., Steggerda, S. J., van Wijk, R., Fransen van de Putte, D. E., & van Kamp, I. L. (2015). Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency ( GPI ) using repeated intrauterine transfusions: a case report. Clinical Case Reports, 3(10), 862–865. https://doi.org/10.1002/ccr3.358

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free